Table 3. Concordance between Systemic Biopsy and MR/US Fusion Prostate Biopsy according to Risk.
| Fusion biopsy | Systemic random biopsy | |||
|---|---|---|---|---|
| No ca | Low | Intermediate | High | |
| PI-RADS 3 | ||||
| No ca | 34 | 1 | 2 | |
| Low | 4 | 7 | ||
| Intermediate | 1 | 2 | ||
| High | 2 | 2 | 2 | |
| p=0.012 | ||||
| PI-RADS 4 | ||||
| No ca | 13 | |||
| Low | 4 | |||
| Intermediate | 2 | 2 | ||
| High | 2 | 1 | 6 | |
| p<0.001 | ||||
| PI-RADS 5 | ||||
| No ca | 1 | |||
| Low | 1 | |||
| Intermediate | 1 | 2 | 1 | |
| High | 1 | 3 | ||
| p=0.691 | ||||
| PI-RADS 3–5 | ||||
| No ca | 48 | 1 | 0 | 2 |
| Low | 4 | 12 | 0 | 0 |
| Intermediate | 0 | 4 | 6 | 1 |
| High | 0 | 4 | 4 | 11 |
| p<0.001 | ||||
MR/US, MRI-ultrasound; Fusion biopsy, MR/US fusion prostate biopsy; PI-RADS, Prostate Imaging Reporting and Data System.